HOLMARC (HOLMARC) fundamentals
HOLMARC is a listed company, part of the Medical Equipment sector, listed on the NSE as HOLMARC (ISIN INE0LXA01019). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What HOLMARC does
Holmarc Opto-Mechatronics Ltd is an India-based company, which is engaged in manufacturing a variety of scientific and engineering instruments for the research, industrial, and educational sectors. Its products include Microscope & Imaging Instruments, Optical Measuring Instruments, Spectroscopy, Analytical Instruments, Lab Equipment’s, Physics Lab Instruments, Breadboards and Tabletops, opt mechanics, Optics, Linear & Rotation Stages, Motorized Linear & Rotation Stages, and Laboratory Automation. Its Microscope & Imaging Instruments include Motorized Digital Holography Microscope, Digital Holography Microscope, Digital Holography Microscope-Inverted, among others. Its Optical Measuring Instruments include Auto Measuring Microscope, Measuring Microscope, Measuring Microscope 215VM, Digital Measuring Microscope, Auto Digital Microscope, and more. Its Spectroscopy includes Spectrometer Goniometer 01, Light Sources, Spectrometer Goniometer Advanced Researcher Version, among others.
Valuation and market data
| Last close | ₹108.70 |
|---|---|
| Market capitalisation | ₹109 crore |
| Enterprise value | ₹102 crore |
| P/E (TTM) | 7.36 |
| Price to book | 4.02 |
| Price to sales (TTM) | 0.91 |
| Book value per share | ₹27.02 |
| Dividend yield | 82.80% |
| Sector | Medical Equipment |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹43 crore | ₹5 crore | ₹4 crore | 0.00 |
| Mar 2025 | ₹38 crore | ₹5 crore | ₹4 crore | 3.72 |
| Mar 2024 | ₹34 crore | ₹5 crore | ₹3 crore | 3.94 |
| Mar 2023 | ₹29 crore | ₹5 crore | ₹4 crore | 4.95 |
| Mar 2022 | ₹21 crore | ₹2 crore | ₹2 crore | 2.16 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 62.7% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 37.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.